CELTIC PHARMA PEG LTD.
CELTIC PHARMA PEG LTD. Patent applications | ||
Patent application number | Title | Published |
---|---|---|
20110183906 | FACTOR IX CONJUGATES WITH EXTENDED HALF-LIVES - The present invention relates to conjugates of Factor IX that have been modified to include a biocompatible polymer moiety. The Factor IX conjugates are substantially free of contamination by Factor IXa. The Factor IX conjugates have improved pharmacokinetic properties, such as increased half-life, which results in dose sparing and less frequent administration. | 07-28-2011 |